Why is クレメンティア trending today?
TrendWhy Research Desk · WORLDWIDE — Sat, 3 Oct, 2026, 05:07 am · 71.1K est. posts
Rank
#23
live chart
Volume
71.1K≈
estimated
Heat
43
0–100 index
Velocity
Stable
low volatility
Peak window: stable plateau · Celebration & amplification dominate conversation.
クレメンティア is trending at No. 23 in Worldwide after a burst of posts tied to breaking coverage — including Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech (Fierce Biotech) and related reporting such as “Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.com”.
クレメンティア is at #23 in Worldwide (~71.1K est. posts, stable) because people are reacting in real time to news about protests or public action, a launch or announcement. Social feeds amplify each new clip, quote, and counter-post, which pushes the keyword up the regional trend board under the Culture umbrella.
Live headlines we read
Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech
Fierce Biotech · Mon, 25 Feb 2019 08:00:00 GMT
Ipsen strikes $1.3B Clementia buyout to boost rare disease unit Fierce Biotech
Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.com
eanews.com · Mon, 09 Mar 2026 07:00:00 GMT
Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” eanews.com
Clementia completes patient enrolment in phase 3 of MOVE Trial - Clinical Trials Arena
Clinical Trials Arena · Fri, 17 Aug 2018 07:00:00 GMT
Clementia completes patient enrolment in phase 3 of MOVE Trial Clinical Trials Arena
Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition - Genetic Engineering and Biotechnology News
Genetic Engineering and Biotechnology News · Tue, 26 Feb 2019 08:00:00 GMT
Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition Genetic Engineering and Biotechnology News
Clementia Pharmaceuticals Inc. Announces Closing of $22.5 Million Series A Financing With Preeminent U.S. and Canadian Healthcare Venture Capital Funds - Yahoo Finance
Yahoo Finance · Thu, 09 Jan 2014 08:00:00 GMT
Clementia Pharmaceuticals Inc. Announces Closing of $22.5 Million Series A Financing With Preeminent U.S. and Canadian Healthcare Venture Capital Funds Yahoo Finance
Board of Trustees Welcomes Two New Members - Colby News
Colby News · Sat, 23 Oct 2021 07:00:00 GMT
Board of Trustees Welcomes Two New Members Colby News
Who · What · When · Where · Why · How
- Who
- Users on X in Worldwide, plus reporters and accounts covering the story (Fierce Biotech, eanews.com, Clinical Trials Arena, Genetic Engineering and Biotechnology News).
- What
- Multiple outlets are covering developments around クレメンティア. Leading headlines include “Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech”; “Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.com”; “Clementia completes patient enrolment in phase 3 of MOVE Trial - Clinical Trials Arena”; “Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition - Genetic Engineering and Biotechnology News”; “Clementia Pharmaceuticals Inc. Announces Closing of $22.5 Million Series A Financing With Preeminent U.S. and Canadian Healthcare Venture Capital Funds - Yahoo Finance”. Fierce Biotech reports: Ipsen strikes $1.3B Clementia buyout to boost rare disease unit Fierce Biotech eanews.com adds: Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” eanews.com
- When
- As of 3/10/2026, 5:07:41 am — live rank #23, ~71.1K est. posts.
- Where
- Worldwide
- Why
- クレメンティア is at #23 in Worldwide (~71.1K est. posts, stable) because people are reacting in real time to news about protests or public action, a launch or announcement. Social feeds amplify each new clip, quote, and counter-post, which pushes the keyword up the regional trend board under the Culture umbrella.
- How
- Through news shares, quote-posts, video clips, and rapid reply chains that feed the trending algorithm.
Data desk
Momentum (last 6 hours)
Hover points for details
Soft purple = volume energy · calm blue dashed = rank (lower is hotter).
Public sentiment
Tone inferred from live headlines and discussion around クレメンティア: currently positive.
- Positive58%
- Neutral28%
- Negative14%
Credibility score
Highly Credible
Highly Credible
Explanation is grounded in 12 live news items (including full-article excerpts). Live chart rank #23 for クレメンティア in Worldwide is independently confirmed. Viral social claims still need primary-source checks.
Conversation mix
Tap or hover a segment
Claim verdict mix
How claims scored
- True21%
- Partial42%
- False21%
- Unverified17%
Soft greens for true, peach for partial, gentle rose for false — easy to scan without alarm fatigue.
Origin story
The conversation intensified as posts about クレメンティア overlapped with reporting from Fierce Biotech, eanews.com, Clinical Trials Arena, Genetic Engineering and Biotechnology News. Quote-posts and reaction threads kept the topic sticky on the live chart until it reached #23.
How it evolved
1:07 am
Early signals
Mentions of クレメンティア begin clustering on timelines in Worldwide.
Mon, 25 Feb 2019 08:00
Fierce Biotech
Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech — Ipsen strikes $1.3B Clementia buyout to boost rare disease unit Fierce Biotech
Mon, 09 Mar 2026 07:00
eanews.com
Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.com — Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” eanews.com
Fri, 17 Aug 2018 07:00
Clinical Trials Arena
Clementia completes patient enrolment in phase 3 of MOVE Trial - Clinical Trials Arena — Clementia completes patient enrolment in phase 3 of MOVE Trial Clinical Trials Arena
4:07 am
Social amplification
クレメンティア is at #23 in Worldwide (~71.1K est. posts, stable) because people are reacting in real time to news about protests or public action, a launch or announcement. Social feeds amplify each new clip, quote, and counte
5:07 am
Live rank #23
クレメンティア holds ~71.1K est. posts on the Worldwide chart. Multiple outlets are covering developments around クレメンティア. Leading headlines include “Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce B
What we know
- クレメンティア is confirmed on the live Worldwide trend list at rank #23 (71.1K est. posts).
- Velocity reading: stable; category signal: Culture.
- Fierce Biotech: “Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech” — Ipsen strikes $1.3B Clementia buyout to boost rare disease unit Fierce Biotech
- eanews.com: “Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.com” — Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” eanews.com
- Clinical Trials Arena: “Clementia completes patient enrolment in phase 3 of MOVE Trial - Clinical Trials Arena” — Clementia completes patient enrolment in phase 3 of MOVE Trial Clinical Trials Arena
- Genetic Engineering and Biotechnology News: “Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition - Genetic Engineering and Biotechnology News” — Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition Genetic Engineering and Biotechnology News
Still unclear
- Some viral posts may exaggerate or invent details not present in published reporting.
- Final outcomes (court, scoreline, policy wording) may still be developing.
Key claims vs reality
Claim: クレメンティア is trending right now in Worldwide.
Reality: Confirmed on the live regional chart at rank #23 (71.1K est. posts).
trueClaim: The story is about: Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech
Reality: This is a leading published headline (Fierce Biotech). Details may still evolve — open the full article.
partialClaim: Everything on X about this is true.
Reality: No. Trend volume amplifies facts, jokes, and false claims together. Use the linked news resources.
falseClaim: Fierce Biotech: “Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech” — Ipsen strikes $1.3B Clementia buyout to boost rare disease
Reality: Listed as a research desk finding from live sources — verify in the original article link.
partial
Bottom line
クレメンティア is trending at No. 23 in Worldwide after a burst of posts tied to breaking coverage — including Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech (Fierce Biotech) and related reporting such as “Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.com”.
What happens next
Follow the linked news stories for updates; chart rank often cools after the first news cycle unless a new development drops.
Resource links
Primary social signal, news, video, and reference material — open in a new tab.
News & reporting
- Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce BiotechFierce Biotech · newsIpsen strikes $1.3B Clementia buyout to boost rare disease unit Fierce Biotechhttps://news.google.com/rss/articles/CBMiogFBVV95cUxOLTZadDE3bVZJYk9QNWttd3BCQzFhZ1ZlbGFoSjducWRkNDA1Y1E4NVNuZG5ZYjA4bjhvbTRFWW0zLXlTS3FBcFRib21lS3o0RmNMMjJQT0h2cGdLLUFYUXFDbGpYTjhKdllJcDNmN1hWMF9fTmE3OW9oNFpqdDZuY2stZmQ4Ynl3YXJ1aUlidFl6Tkg0SmJMbnplbWlIS2tKQVE?oc=5
- Clementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” - eanews.comeanews.com · newsClementia Eugene: “Women Must Let Go of the Obligation to Always Appear Strong and Focus on Healing” eanews.comhttps://news.google.com/rss/articles/CBMivgFBVV95cUxNRlJFaXJfVG9KRzYwX3gta1ZRb0RlRDRubkFSeTFnMExjc1JHSVJ0NUFmTkttYjRURi12UkpBUkJLMkhSOWxJMlRTc0ZqTUFWUjEwQTdrZ3hkY0Y2TTU3X0wyUU9IR1NYTGZ0UlA5eFc5blYzdnktR1VIMlY3eEJaNkJ3RlhObXBnSW5kYlFEVTNjTmxkU3FtdTlaWkQtLXhpa25kOGlzS2U1TkppMHBwQnZuQjczMHhfVHdncGhB?oc=5
- Clementia completes patient enrolment in phase 3 of MOVE Trial - Clinical Trials ArenaClinical Trials Arena · newsClementia completes patient enrolment in phase 3 of MOVE Trial Clinical Trials Arenahttps://news.google.com/rss/articles/CBMinwFBVV95cUxPQVByd0cxZ0tENGxhVjlwLU1vdmVoOE9jMGJfS3dsQUNGRTZZb0pQeVc2SHBxN3VaOERfV1BZajdCal9LRnBhOXZ1SzJpOHo1N0dUX2NKaFI5MGMwVTdXU0Z2Mk5odXl1dUN3YUx4c0JnNHR3ZEd3ZTdMVUptNlFmZjZfWDVmekFSV0VCMVZEWnJqRk9vZHh2NDR5WjVhZlE?oc=5
- Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · newsRoche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition Genetic Engineering and Biotechnology Newshttps://news.google.com/rss/articles/CBMiugFBVV95cUxPb0x1dTlxbmtkTEcza1ZoMWI5M3NYei1zOXhyNU1IM0tKZmUxWnFqd3BFYmRsR21GYWVVNl9LQzdMbzFNSC12RU1zZy1UN2t6Smw4RENEZElJcjg2Nm1jTDdWRVN2MERsUU10ajBuS0NrbVpEaUY3UV9VMGVjcWlXMmJYQmc5U1MyUGpPS0xiUXpNclZPOFBWdmxaNGxxeG15am1xY21yOEhDdmpYZjV1cFM2VXlSOEU3MXc?oc=5
- Clementia Pharmaceuticals Inc. Announces Closing of $22.5 Million Series A Financing With Preeminent U.S. and Canadian Healthcare Venture Capital Funds - Yahoo FinanceYahoo Finance · newsClementia Pharmaceuticals Inc. Announces Closing of $22.5 Million Series A Financing With Preeminent U.S. and Canadian Healthcare Venture Capital Funds Yahoo Financehttps://news.google.com/rss/articles/CBMimAFBVV95cUxOanhIQzJaY0lUalJkdDRlcnZTLXB0MzdEODZBa1ZVc21sS1lXT1pPU1c5WGhHUXZkdVBGMkxqZWVOUk5jYmMtOU1uSjREZ3hOWHZGTHdZa0NKQldLVmJYeVk2RkRXWktaRC13LS1jOEgyRDRBN1l4d2tZVVV6RWQ2NjNiSlNOc1NGOGxVZ1dIdGZLV2s1WUh6UQ?oc=5
- Board of Trustees Welcomes Two New Members - Colby NewsColby News · newsBoard of Trustees Welcomes Two New Members Colby Newshttps://news.google.com/rss/articles/CBMifEFVX3lxTE9HTm1QdkJDRjhWNHY2ZURRbFdvRUFSVDMwaHhUR1NNTjFPazJKRTJFTndpMVNlc1VNMkJ3cmhhUENxQnBxMVYtY2pzOWlqQXl6anZxdXJqdV94XzZ0YzF3TUFyVzRWWVljRlJDeGN1YURVNDZuWFhURFYzWGc?oc=5
- Slain teen's mother will remember Mayor Tom Menino's humility - wcvb.comwcvb.com · newsSlain teen's mother will remember Mayor Tom Menino's humility wcvb.comhttps://news.google.com/rss/articles/CBMinAFBVV95cUxPemxleHo4MDl6Rmo3ckN0MHVmTHg2SUN4NndPQ3poSkdBcHVnekRJeVFUZkJyWUlmN3gtUUZSZ0tJTHBya3htNjFnUEJ1TUJVTFdTcFRCUjV2RkZqRmppWnNkYVhNZ2pMNnNQbVpTdW5VOWIwbHhZNnZHbTgwMkxWbWdhQ3h6Vk5UOEtJWmh4TGJSRmZia3k4eVdDdGQ?oc=5
- Artist Ment Nelson using Gullah Geechee heritage as inspiration - WCIVWCIV · newsArtist Ment Nelson using Gullah Geechee heritage as inspiration WCIVhttps://news.google.com/rss/articles/CBMiiwFBVV95cUxQbm1NWmVzWEFPcnJqUUdIRmR1aTc4NEdsc2Z3N3BWVjlZMzMyMS1jdUVJV0pzdThhZXVSdXZRb1VQMmd0aTNLNE4tcEhaOXh0ZWNueWMxREdrMW93X01zMjVBcE5KWm8tTEhtQmMwS2cxNEhvSnBpdldEbDF2Y2psd1NvZHhyT3JvSWZ3?oc=5
- Students from DPS STS School Dhaka win first prize - The Financial ExpressThe Financial Express · newsStudents from DPS STS School Dhaka win first prize The Financial Expresshttps://news.google.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?oc=5
- 4 years later, Ipsen's 'de-risked' rare disease drug Sohonos finally gains FDA approval - fiercepharma.comfiercepharma.com · news4 years later, Ipsen's 'de-risked' rare disease drug Sohonos finally gains FDA approval fiercepharma.comhttps://news.google.com/rss/articles/CBMipAFBVV95cUxNOWRheW1TMnkwZko2Y3RNSXZFUFhGTVlDVUVIYVVuQUhfTjBBRmtuT21pRHRDQzVLUDdLSmxQNzBFdExiTkJsWTNXUmljN2JFR1dyN0lsb1dDbXJuemxnaVdtbXB1Ny16Y09wWXpSd1hieHRjNHg4dGRERWJ1cmQ5SG5oaVAtVXl0ZXRIQTJaaFQwcGd4VTZ4TGU3bWVHRWota3JwOQ?oc=5
- Google News: クレメンティアGoogle News · newsFull live news search resultshttps://news.google.com/search?q=%E3%82%AF%E3%83%AC%E3%83%A1%E3%83%B3%E3%83%86%E3%82%A3%E3%82%A2&hl=en-IN&gl=IN&ceid=IN:en
Social & video
- Live posts about クレメンティアX (Twitter) · xLatest posts matching this trendhttps://x.com/search?q=%E3%82%AF%E3%83%AC%E3%83%A1%E3%83%B3%E3%83%86%E3%82%A3%E3%82%A2&src=typed_query&f=live
- Top posts: クレメンティアX (Twitter) · xHighest-engagement postshttps://x.com/search?q=%E3%82%AF%E3%83%AC%E3%83%A1%E3%83%B3%E3%83%86%E3%82%A3%E3%82%A2&src=typed_query&f=top
- YouTube: クレメンティアYouTube · youtubeVideo coverage and explainershttps://www.youtube.com/results?search_query=%E3%82%AF%E3%83%AC%E3%83%A1%E3%83%B3%E3%83%86%E3%82%A3%E3%82%A2
- Reddit: クレメンティアReddit · redditCommunity discussionhttps://www.reddit.com/search/?q=%E3%82%AF%E3%83%AC%E3%83%A1%E3%83%B3%E3%83%86%E3%82%A3%E3%82%A2&sort=new
Related hashtags
Creator Mode
Lead with the confirmed action: Multiple outlets are covering developments around クレメンティア. Leading headlines include “Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech”; “Clementia . Then explain social velocity (#23 in Worldwide). End with 2 source screenshots.
- · Why is クレメンティア trending in Worldwide right now?
- · クレメンティア: what “Ipsen strikes $1.3B Clementia buyout to boost rare disease unit - Fierce Biotech” means
- · Simple context for クレメンティア